Recently developed second-generation tracers, such as PI-2620, show high sensitivity for detecting tau accumulation in AD and FTLD-tau cases, such as 4R-related PSP and CBS (Brendel et al., 2020; Palleis et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.